Program manager of business intelligence, biostats, and advanced performance analytics platforms. Successfully saved multiple millions of dollars over several years (saved batches, favorable variances, cycle time efficiencies) by deploying distinct data science capabilities that turn advanced analytics and visualizations into tangible business value. That’s the endgame, and by directing database and software architecture and programs toward effective continuous improvements across pharmaceutical manufacturing sites in a global network. We target cost of goods reductions, throughput efficiency and real-time predictive analytics of critical manufacturing steps, bottlenecks, and the visualization/consumption to deliver real-time actionable insights to managers and site leads.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.